Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

818.02
-21.9400-2.61%
Post-market: 816.75-1.2700-0.16%18:31 EDT
Volume:3.33M
Turnover:2.73B
Market Cap:775.47B
PE:69.86
High:843.91
Open:841.51
Low:807.00
Close:839.96
Loading ...

Why Eli Lilly and Company (LLY) is Skyrocketing?

Insider Monkey
·
18 Apr

Market Chatter: Eli Lilly Releases Obesity Drug Zepbound in Japan

MT Newswires Live
·
18 Apr

Eli Lilly stock prices boom, here's the secret behind it

ByShrey Banerjee
·
18 Apr

Post-Bell | U.S. Stocks Mixed; Hertz Soars Another 44%; Eli Lilly Surges 14%; Nvidia Drops 3%; UnitedHealth Plunges 22%

Tiger Newspress
·
18 Apr

Chugai Highlights Eli Lilly’s Promising Phase 3 Results for Orforglipron

TIPRANKS
·
18 Apr

Dow, Nasdaq Fall For Third Straight Day as Markets Log Weekly Losses

MT Newswires
·
18 Apr

Eli Lilly & Co. Stock Advances 14.3%, Outperforms Competitors

Dow Jones
·
18 Apr

TRADING DAY-ECB acts, Trump attacks

Reuters
·
18 Apr

US Equities Markets End Mixed Thursday Ahead of Good Friday Holiday

MT Newswires Live
·
18 Apr

US STOCKS-S&P 500 ends up as Eli Lilly jumps and UnitedHealth plummets

Reuters
·
18 Apr

Equity Markets Mixed as Trump Calls for Interest Rate Cuts

MT Newswires Live
·
18 Apr

Novo Nordisk downgraded by BMO as Eli Lilly gains ground in weight-loss drug race

Investing.com
·
18 Apr

Eli Lilly (NYSE:LLY) Partners With BigHat And Achieves Phase 3 Success With Orforglipron

Simply Wall St.
·
18 Apr

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Motley Fool
·
18 Apr

Why Is Eli Lilly (LLY) Stock Rocketing Higher Today

StockStory
·
18 Apr

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

Reuters
·
18 Apr

Eli Lilly : Jefferies Raises Target Price to $1057 From $1020

THOMSON REUTERS
·
17 Apr

Eli Lilly’s Stock Soars After Weight-Loss Pill Competing with Ozempic Shows Promise

CoinMarketCap
·
17 Apr

Novo Nordisk's ADRs Slide After Eli Lilly Obesity Pill Results -- Market Talk

Dow Jones
·
17 Apr

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

TIPRANKS
·
17 Apr